Haemonetics Corporation Asset Resilience Ratio
Haemonetics Corporation asset resilience ratio. Haemonetics Corporation (HAE) has an Asset Resilience Ratio of 14.59% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Haemonetics Corporation (HAE) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Haemonetics Corporation (1997–2025)
Asset resilience ratio of Haemonetics Corporation from 1997 to 2025. This chart shows how Haemonetics Corporation's Asset Resilience Ratio has changed over time. See Haemonetics Corporation (HAE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Haemonetics Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see HAE total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $363.37 Million | 14.59% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $363.37 Million | 14.59% |
Asset Resilience Insights
- Moderate Liquidity: Haemonetics Corporation has 14.59% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Haemonetics Corporation Industry Peers by Asset Resilience Ratio
Compare Haemonetics Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1 |
Medical Devices | 1.05% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Wellell Inc
TW:4106 |
Medical Devices | 2.43% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 15.99% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
Haemonetics Corporation Asset Resilience Ratio by Year (1997–2025)
Haemonetics Corporation asset resilience ratio by year from 1997 to 2025. The table below shows the annual Asset Resilience Ratio data for Haemonetics Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 12.52% | $306.76 Million | $2.45 Billion | +4.30pp |
| 2024-03-31 | 8.22% | $180.47 Million | $2.20 Billion | -6.54pp |
| 2023-03-31 | 14.76% | $285.58 Million | $1.93 Billion | +0.81pp |
| 2022-03-31 | 13.95% | $259.50 Million | $1.86 Billion | +3.39pp |
| 2021-03-31 | 10.57% | $192.31 Million | $1.82 Billion | -0.27pp |
| 2020-03-31 | 10.84% | $137.31 Million | $1.27 Billion | -2.45pp |
| 2019-03-31 | 13.28% | $169.35 Million | $1.27 Billion | -1.28pp |
| 2018-03-31 | 14.56% | $180.17 Million | $1.24 Billion | +3.29pp |
| 2017-03-31 | 11.27% | $139.63 Million | $1.24 Billion | -- |
| 2016-03-31 | 0.00% | $0.00 | $1.32 Billion | -- |
| 2015-03-31 | 0.00% | $0.00 | $1.48 Billion | -- |
| 2014-03-31 | 0.08% | $1.25 Million | $1.52 Billion | -- |
| 2013-03-31 | 0.00% | $0.00 | $1.46 Billion | -- |
| 2012-03-31 | 0.00% | $0.00 | $910.63 Million | -- |
| 2011-03-31 | 0.00% | $0.00 | $833.26 Million | -- |
| 2004-03-31 | 0.47% | $1.90 Million | $407.39 Million | -0.29pp |
| 2003-03-31 | 0.75% | $2.70 Million | $359.21 Million | -8.19pp |
| 2002-03-31 | 8.94% | $32.64 Million | $364.92 Million | -0.63pp |
| 2001-03-31 | 9.57% | $33.04 Million | $345.31 Million | +7.28pp |
| 2000-03-31 | 2.29% | $8.00 Million | $349.11 Million | -1.16pp |
| 1999-03-31 | 3.45% | $12.30 Million | $356.40 Million | -0.08pp |
| 1998-03-31 | 3.53% | $11.90 Million | $336.70 Million | -0.67pp |
| 1997-03-31 | 4.20% | $13.60 Million | $323.50 Million | -- |
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more